Ferronova is an innovative medical device company, spun out of the University of South Australia and Victoria University of Wellington NZ, and licensing core intellectual property from the University of Sydney, producing advanced magnetic nanoparticles to aid in the diagnosis and treatment of cancer. Ferronova's mission is to provide solutions for staging all solid tumour cancers.
Founded in 2016, Ferronova seed funding was by ASX-listed investment group Powerhouse Ventures, UniSA Ventures and Wellington Univentures. The SA Government has provided grant funding.
Major Series A investors are Uniseed, Artesian Venture Partners, the South Australian Venture Capital Fund (SAVCF), and PAN Ventures.